SIGHT SCIENCES INC
(NASDAQ: SGHT)

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

5.810

+0.260 (+4.68%)
Range - - -   (-%)
Open -
Previous Close 5.550
Bid Price 8.660
Bid Volume 18
Ask Price 9.090
Ask Volume 12
Volume 48,938
Value -
Remark
Delayed prices. Updated at 17 May 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis